ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Ginsenoside Rh2 inhibits non-small-cell lung cancer malignant progression through targeting AURKA.

Yuanyuan Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.